ARLINGTON, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of ...
Adam Hort leads by 83 votes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback